Abstract
In the large-scale international, multicenter randomized EXCEL trial, PCI with everolimus-eluting stents (EES) was non-inferior to CABG in pts with left main coronary artery disease (LMCAD) and SYNTAX scores ≤32 at median 3-year (3Y) follow-up. Given the impact of age on outcomes after
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
